Severity of COVID-19 manifestations in HIV patients: a systematic review and meta-analysis
CONCLUSIONS: PLWHs and HIV-negative individuals showed comparable rates and intensity of COVID-19. ART users exhibited immunological health comparable to immunocompetent people, demonstrating the essential role of ART in reducing the severity and mortality of PLWH with COVID-19.PMID:38567616 | DOI:10.26355/eurrev_202403_35763 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: A Alam A A Soeroto R A Susilohadi L A Chandra Source Type: research

Evaluation of vaccine effectiveness of mRNA COVID-19 vaccines in children: a systematic review and meta-analysis
CONCLUSIONS: Both partial and full immunization of the BNT162b2 mRNA vaccine provide benefits in reducing infection rates. VE varies over time and is closely associated with viral mutations and waning immunity. The specific mechanisms require further investigation.PMID:38567617 | DOI:10.26355/eurrev_202403_35764 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: Y-H Hu Y Ding L-W Li J Cheng Y-H Cai Source Type: research

Post-COVID syndrome: analysis of the prevalence of chemosensory dysfunction and predictive factors of recovery in COVID-19 long-haulers in Jordan
CONCLUSIONS: Chemosensory dysfunctions are largely subjective; therefore, more objective examinations are required to draw more definite conclusions.PMID:38567618 | DOI:10.26355/eurrev_202403_35765 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: H M Sawan A H Khalifeh M Ahmed M M Khalil S M Al Omari R Binsuwaidan Source Type: research

Evaluation of the hematological and immunological markers after the first and second doses of BNT162b2 mRNA vaccine
CONCLUSIONS: We can conclude that the Pfizer/BioNTech vaccine produced a more potent T-cell response than humoral ones.PMID:38567619 | DOI:10.26355/eurrev_202403_35766 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: M Rafeeq M S Jabir H M Al-Kuraishy Z M A Jeddoa S F Jawad M A A Najm A F Almulla E Elekhnawy J Z Tayyeb A Turkistani B A Alsfouk G E Batiha Source Type: research

COVID-19 post-traumatic stress disorder: the role of ACEs, alexithymia, and attachment in the Italian population
CONCLUSIONS: Emotional regulation and attachment have been shown to be risk factors for COVID-19 PTSD symptomatology. Focused intervention programs and emotional education can be useful tools for developing protective factors in the general population.PMID:38567620 | DOI:10.26355/eurrev_202403_35767 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: S Monaco M G Massari A Renzi M Di Trani Source Type: research

Retraction Note: Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2625. doi: 10.26355/eurrev_202403_35774.ABSTRACTThe article "Presence of viral spike protein and vaccinal spike protein in the blood serum of patients with long-COVID syndrome", by K. Dhuli, M.C. Medori, C. Micheletti, K. Donato, F. Fioretti, A. Calzoni, A. Praderio, M.G. De Angelis, G. Arabia, S. Cristoni, S. Nodari, M. Bertelli, published in Eur Rev Med Pharmacol Sci 2023; 27 (6 Suppl): 13-19-DOI: 10.26355/eurrev_202312_34685-PMID: 38112944 has been retracted by the Editor in Chief for the following reasons. Following some concerns raised on PubPeer, the Editor in Chief has start...
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: K Dhuli M C Medori C Micheletti K Donato F Fioretti A Calzoni A Praderio M G De Angelis G Arabia S Cristoni S Nodari M Bertelli Source Type: research

Author Correction: Aldo-keto reductase 1C2 (AKR1C2) as the second gene associated to non-syndromic primary lipedema: investigating activating mutation or overexpression as causative factors
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2626. doi: 10.26355/eurrev_202403_35776.ABSTRACTCorrection to: Eur Rev Med Pharmacol Sci 2023; 27 (6 Suppl): 127-136-DOI: 10.26355/eurrev_202312_34697 After publication and following some post-publication concerns, the authors have applied the following corrections to the galley proof. - The conflict of interest section has been amended as follows: J. Kaftalli and G. Marceddu are employees at MAGI EUREGIO. K. Donato is employee at MAGI EUREGIO and MAGISNAT. M. Bertelli is president of MAGI EUREGIO, MAGISNAT, and MAGI's LAB. G. Bonetti, K. Dhuli, A. Macchia, and P.E. Maltese are emp...
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: J Kaftalli K Donato G Bonetti K Dhuli A Macchia P E Maltese K Louise Herbst S Michelini P Chiurazzi M Hill S Michelini S Michelini G Marceddu A Bernini M Bertelli Source Type: research

Author Correction: Genetic variants identified in novel candidate genes for anorexia nervosa and analysis of molecular pathways for diagnostic applications
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2627. doi: 10.26355/eurrev_202403_35779.ABSTRACTCorrection to: Eur Rev Med Pharmacol Sci 2023; 27 (6 Suppl): 77-88-DOI: 10.26355/eurrev_202312_34692 After publication and following some post-publication concerns, the authors have applied the following corrections to the galley proof. The conflict of interest section has been amended as follows: K. Donato is employee at MAGI EUREGIO and MAGISNAT. G. Marceddu is employee at MAGI EUREGIO. M. Bertelli is president of MAGI EUREGIO, MAGISNAT, and MAGI's LAB. M.C. Medori, A. Macchia, S. Cecchin, C. Micheletti, K. Dhuli, G. Madeo, G. Bonet...
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: K Donato M C Medori A Macchia S Cecchin M R Ceccarini T Beccari V Gatta L Stuppia V Benfatti L Dalla Ragione P Chiurazzi C Micheletti K Dhuli G Madeo G Bonetti G Marceddu M Bertelli Source Type: research

Author Correction: Achievement of sustainable development goals through the Mediterranean diet
Eur Rev Med Pharmacol Sci. 2024 Mar;28(6):2628. doi: 10.26355/eurrev_202403_35781.ABSTRACTCorrection to: Eur Rev Med Pharmacol Sci 2023; 27 (6 Suppl): 89-99-DOI: 10.26355/eurrev_202312_34693 After publication and following some post-publication concerns, the authors have applied the following corrections to the galley proof. - The conflict of interest section has been amended as follows: M.C. Medori and D. Malacarne are employees at MAGI'S LAB. K. Donato is employee at MAGI EUREGIO and MAGISNAT. M. Bertelli is president of MAGI EUREGIO, MAGISNAT, and MAGI's LAB. E. Borghetti is president at AERSAFE srl. C. Zuccato is resea...
Source: Pharmacological Reviews - April 3, 2024 Category: Drugs & Pharmacology Authors: M C Medori K Donato L Stuppia T Beccari M Dundar R S Marks S Michelini E Borghetti C Zuccato L Seppilli H Elsangak G Sozanski D Malacarne M Bertelli Source Type: research

The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease
Expert Rev Clin Pharmacol. 2024 Mar 22:1-4. doi: 10.1080/17512433.2024.2333776. Online ahead of print.NO ABSTRACTPMID:38511397 | DOI:10.1080/17512433.2024.2333776 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 21, 2024 Category: Drugs & Pharmacology Authors: Panagiotis I Georgianos Vasilios Vaios Ioannis Kontogiorgos Maria Divani Vassilios Liakopoulos Source Type: research

The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease
Expert Rev Clin Pharmacol. 2024 Mar 22:1-4. doi: 10.1080/17512433.2024.2333776. Online ahead of print.NO ABSTRACTPMID:38511397 | DOI:10.1080/17512433.2024.2333776 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 21, 2024 Category: Drugs & Pharmacology Authors: Panagiotis I Georgianos Vasilios Vaios Ioannis Kontogiorgos Maria Divani Vassilios Liakopoulos Source Type: research

The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease
Expert Rev Clin Pharmacol. 2024 Mar 22:1-4. doi: 10.1080/17512433.2024.2333776. Online ahead of print.NO ABSTRACTPMID:38511397 | DOI:10.1080/17512433.2024.2333776 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 21, 2024 Category: Drugs & Pharmacology Authors: Panagiotis I Georgianos Vasilios Vaios Ioannis Kontogiorgos Maria Divani Vassilios Liakopoulos Source Type: research

The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease
Expert Rev Clin Pharmacol. 2024 Mar 22:1-4. doi: 10.1080/17512433.2024.2333776. Online ahead of print.NO ABSTRACTPMID:38511397 | DOI:10.1080/17512433.2024.2333776 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 21, 2024 Category: Drugs & Pharmacology Authors: Panagiotis I Georgianos Vasilios Vaios Ioannis Kontogiorgos Maria Divani Vassilios Liakopoulos Source Type: research

The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease
Expert Rev Clin Pharmacol. 2024 Mar 22:1-4. doi: 10.1080/17512433.2024.2333776. Online ahead of print.NO ABSTRACTPMID:38511397 | DOI:10.1080/17512433.2024.2333776 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 21, 2024 Category: Drugs & Pharmacology Authors: Panagiotis I Georgianos Vasilios Vaios Ioannis Kontogiorgos Maria Divani Vassilios Liakopoulos Source Type: research

The thiazide-like diuretic chlorthalidone as an alternative evidence-based therapy for resistant hypertension in patients with stage 4 chronic kidney disease
Expert Rev Clin Pharmacol. 2024 Mar 22:1-4. doi: 10.1080/17512433.2024.2333776. Online ahead of print.NO ABSTRACTPMID:38511397 | DOI:10.1080/17512433.2024.2333776 (Source: Pharmacological Reviews)
Source: Pharmacological Reviews - March 21, 2024 Category: Drugs & Pharmacology Authors: Panagiotis I Georgianos Vasilios Vaios Ioannis Kontogiorgos Maria Divani Vassilios Liakopoulos Source Type: research